Premedication to Reduce Amivantamab Associated Infusion Related Reactions
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Takeda
Barbara Ann Karmanos Cancer Institute
Checkpoint Therapeutics, Inc.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
University of Arizona
Amgen
Stanford University
Boehringer Ingelheim
Sun Yat-sen University
University of Kentucky
Eli Lilly and Company